⌘K

Login Start Free

Home/Filings/4/0000711377-17-000048

4//SEC Filing

BRADLEY EDWARD 4

Accession 0000711377-17-000048

CIK 0000711377other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 9:03 PM ET

Size

15.6 KB

Accession

0000711377-17-000048

Insider Transaction Report

Form 4

Period: 2017-11-17

NEOGEN CORPNEOG

Vice President

Transactions

Sale
Common Stock
2017-11-17$80.32/sh−17,824$1,431,624→ 21,512 total
Exercise/Conversion
Common Stock (Right to Buy)
2017-11-17−6,124→ 6,124 total
Exercise: $47.12Exp: 2020-11-08→ Common Stock (6,124 underlying)
Exercise/Conversion
Common Stock
2017-11-17$47.12/sh+6,124$288,563→ 33,336 total
Exercise/Conversion
Common Stock (Right to Buy)
2017-11-17−5,700→ 71,173 total
Exercise: $39.61Exp: 2019-10-31→ Common Stock (5,700 underlying)
Exercise/Conversion
Common Stock
2017-11-17$39.61/sh+5,700$225,777→ 27,212 total
Exercise/Conversion
Common Stock
2017-11-17$53.95/sh+6,000$323,700→ 39,336 total
Exercise/Conversion
Common Stock (Right to Buy)
2017-11-17−6,000→ 59,049 total
Exercise: $53.95Exp: 2021-10-29→ Common Stock (6,000 underlying)

Footnotes (3)

[F1]Options were granted 10/1/2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
[F2]Options were granted 10/8/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
[F3]Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NEOGEN CORP

CIK 0000711377

Entity typeother

Related Parties

1

filerCIK 0001189021

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 9:03 PM ET
Size: 15.6 KB

View on SEC.gov